Request Demo
Last update 01 Nov 2024
CysLT1 x NKCC2 x Phosphoric diester hydrolases x PDE4 x SLC12A4 x PGI2 receptor x PDE3 x NKCC1
Last update 01 Nov 2024
Basic Info
Related Targets |
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT04644003
A Phase 1b, Double-Blind, Placebo-Controlled, First-in-Human Study to Evaluate Safety, Tolerability and Pharmacokinetics of a Two-Week Oral Treatment With STP1 in a Subgroup of Patients With Autism Spectrum Disorder
100 Clinical Results associated with CysLT1 x NKCC2 x Phosphoric diester hydrolases x PDE4 x SLC12A4 x PGI2 receptor x PDE3 x NKCC1
Login to view more data
100 Translational Medicine associated with CysLT1 x NKCC2 x Phosphoric diester hydrolases x PDE4 x SLC12A4 x PGI2 receptor x PDE3 x NKCC1
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free